ANXA6 and muscular dystrophy: Additionally, we evaluated the response to a resealing protein, recombinant annexin A6, which was previously identified as a genetic modifier of muscular dystrophy and a potential therapeutic target (Demonbreun et al., 2019; Swaggart et al., 2014).